Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-04-12

FDA Approved: SORAFENIB — Original Application (Torrent Pharmaceuticals Limited)

View source ↗

Summary

The FDA approved Torrent Pharmaceuticals' original ANDA for sorafenib, a generic version of Nexavar, expanding access to the cancer therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sorafenib (Sorafenib)

Snippet

ORIG AP for SORAFENIB (SORAFENIB)